Kymera Therapeutics, Inc. · NASDAQ:KYMR

Baker Bros. Advisors LP reported a 10.90% stake in Kymera Therapeutics, Inc. (Schedule 13D/A)

Event Dec 9, 2025 · Filed Dec 11, 2025

Baker Bros. Advisors LP reported a 10.90% stake in Kymera Therapeutics, Inc., 8,676,797 shares, with active intent on Dec 9, 2025. Filed Dec 11, 2025 (Schedule 13D/A).

Stake
10.90%
Shares
8,676,797
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Baker Bros. Advisors LP10.90%8,676,797
Baker Bros. Advisors (GP) LLC10.90%8,676,797
Julian C. Baker10.90%8,676,797
Felix J. Baker10.90%8,676,797

Source

View original at SEC

Related